METHOD, MANUFACTURING METHOD, DESIGN DEVICE, DESIGN PROGRAM, AND RECORDING MEDIUM FOR PRIMER FOR AMPLICON METHYLATION SEQUENCE ANALYSIS

    公开(公告)号:US20230290442A1

    公开(公告)日:2023-09-14

    申请号:US18321106

    申请日:2023-05-22

    发明人: Naoko YAMAGUCHI

    摘要: An object of the present invention is to provide a design method, a manufacturing method, a design device, a design program, and a recording medium of a primer for amplicon methylation sequence analysis, which can improve a design success rate of the primer. The present invention is a primer design method for amplicon methylation sequence analysis, the method having a base conversion step of converting methylatable “C” into “Y” and converting other “C” into “T” in double-stranded genomic DNA, and a primer candidate sequence selection step of selecting sequences satisfying predetermined selection conditions as primer candidate sequences, in which the methylatable C is C in a CG sequence, and the predetermined selection conditions include (1) a Tm value is within a predetermined range, (2) the number of YG sequences or CR sequences included in a partial sequence is equal to or less than a predetermined, and (3) an upper limit of the number of binding sites with a sequence outside the related region on the double-stranded genomic DNA after base conversion is equal to or less than a predetermined number that is 1 or more.

    Method of Determining a Quantitative Fingerprint of a Subset of Bacteria in a Person's Gastrointestinal Microbiome

    公开(公告)号:US20230227892A1

    公开(公告)日:2023-07-20

    申请号:US17576865

    申请日:2022-01-14

    申请人: mbiomics GmbH

    IPC分类号: C12Q1/6816 C12Q1/6876

    CPC分类号: C12Q1/6816 C12Q1/6876

    摘要: The relative abundance of bacterial species in a patient’s microbiome is quantified using DNA nanostructures that fluoresce multiple colors. Immobilizing binders have binding sites with nucleotide sequences complementary to those at a primary site on rRNA subunits of each selected bacterial species. Fluorophore binders have binding sites with nucleotide sequences complementary to those at a secondary site on the rRNA subunits. The fluorophore binders for each bacterial species are attached to nanostructures that fluoresce a particular color for each bacteria. The immobilizing binders are attached to the surface of a microscopy chamber. RNA subunits are extracted from a microbiome sample of the patient and are attached to the corresponding immobilizing binders and fluorophore binders such that the RNA subunits of each bacterial species fluoresce a color unique to the species. DNA nanostructures emitting the same color are counted to determine the relative concentration of the bacterial species in the sample.